Experts, Activists Call For Stricter Regulation Of Indian Pharmaceutical Industry After Sterilization Deaths

Financial Times: Sterilization tragedy highlights India’s bad-drug crisis
“…While final forensic results are still awaited, Indian drug industry executives and health activists say the questions over the medicine distributed at the sterilization camp [where 13 women died last week] highlights the urgent need for tougher regulation of India’s domestic pharmaceutical industry…” (Kazmin, 11/19).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.